▸
▾
Claim This Listing
Please login in order to be able to claim this listing.
You are not currently logged in. Please login or register first. When registering, you will receive an activation email. Be sure to check your spam if you don’t see it in your email within 60 minutes.
Login
Vesselon, Inc.
Vesselon, Inc., is developing VEST™, a novel therapeutic immuno-oncology complex that protects and targets tumors. VEST™ stands for Vascular Encapsulation Sonication Targeting and is comprised of three FDA approved elements: Imagent, a lipid microsphere drug; standard ultrasound equipment; and oncology drugs, all combined as drug/drug platform technology. Vesselon’s proprietary complexes work across a spectrum of cancers and other serious diseases with a variety of drug classes.
